Alembic Pharmaceuticals informs about incorporation of wholly-owned subsidiary company
Alembic Pharmaceuticals has informed that the Company has incorporated a wholly owned subsidiary named Alembic Pharmaceuticals GmbH in Germany. The disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the aforesaid incorporation is enclosed as Annexure - I.
The above information is a part of company’s filings submitted to BSE.
